Optimising patient isolation due to meticillin-resistant Staphylococcus aureus;Optimalisering van isolatieverpleging vanwege meticillineresistente Staphylococcus aureus

Nederlands Tijdschrift voor Geneeskunde

Volumn 149, Issue 15, 2005, Pages 794-796

  Kluytmans, J A J W ^a   Van Den Broek, P J ^b  

^a AMPHIA HOSPITAL   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; ENDEMIC DISEASE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE QUALITY; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NETHERLANDS; PATIENT CARE; REVIEW;

CROSS INFECTION; HUMANS; METHICILLIN RESISTANCE; NETHERLANDS; ORGANIZATIONAL POLICY; PATIENT ISOLATION; QUALITY OF HEALTH CARE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 17144364677     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Stelfox HT, Bates DW, Redelmeier DA. Safety of patients isolated for infection control. JAMA 2003;290:1899-905.
2. Cooper BS, Stone SP, Kibbler CC, Cookson BD, Roberts J, Medley GF, et al. Systematic review of isolation policies in the hospital management of methicillin-resistant Staphylococcus aureus: a review of the literature with epidemiological and economic modelling. Health Technol Asses 2003;7:1-194.
3. Reacher MH, Shah A, Livermore DM, Wale MC, Graham C, Johnson AP, et al. Bacteremia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. BMJ 2000;320:213-6.
4. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36:53-9.
5. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb Mortal Wkly Rep 2002;51:565-7.
6. Duckworth G. Controlling methicillin resistant Stahylococcus aureus; time to return to more stringent methods of control in the United Kingdom? BMJ 2003;327:1177-8.
7. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003;24:302-86.
8. Vriens MR, Blok HEM, Fluit AC, Troelstra A, Werken Chr van der, Verhoef J. Kosten van het huidige infectiepreventiebeleid voor meticillineresistente Staphylococcus aureus (MRSA) beduidend lager dan bij loslaten van dat beleid; een retrospectief onderzoek over 10 jaar in het Universitair Medisch Centrum Utrecht. Ned Tijdschr Geneeskd 2004;148:1048-52.